Skip to main content

Amygdala-liver signalling orchestrates glycaemic responses to stress.

Nature2025-09-04PubMed
Total: 88.5Innovation: 9Impact: 0Rigor: 0Citation: 0

Summary

This study delineates a neural–humoral pathway from the amygdala to the liver that acutely regulates blood glucose in response to stress. Using multimodal experiments, the authors show that amygdala-driven signaling orchestrates hepatic glucose output, defining a mechanistic basis for stress hyperglycaemia.

Key Findings

  • Identifies an amygdala-to-liver signaling pathway that regulates hepatic glucose output during stress.
  • Demonstrates that neural control from the amygdala orchestrates systemic glycaemic responses.
  • Provides mechanistic insight into stress hyperglycaemia beyond peripheral hormonal changes.

Clinical Implications

Targets within the amygdala–liver axis could be leveraged to blunt stress-induced hyperglycaemia in diabetes and critical illness, complementing peripheral glucose-lowering therapies.

Why It Matters

Revealing a brain–liver circuit for stress glycaemia reframes neuroendocrine control of metabolism and opens therapeutic avenues for stress-exacerbated hyperglycaemia.

Limitations

  • Preclinical model limits immediate translation to humans.
  • Abstracted details on specific molecular mediators are not provided in the summary text.

Future Directions

Define molecular effectors linking amygdala activity to hepatic glucose metabolism and test translatability in human neuroimaging and interventional studies.

Study Information

Study Type
Case series
Research Domain
Pathophysiology
Evidence Level
V - Preclinical mechanistic experiments; no direct clinical outcomes.
Study Design
OTHER